Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA® (bendamustine hydrochloride) injection, for intravenous useTREANDA® (bendamustine hydrochloride) for injection, for intravenous useInitial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
TREANDA® is indicated for the treatment of patients with chronic lymphocytic leukemia. Efficacy relative to first line therapies other than chlorambucil has not been established. TREANDA is indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
- generic_name
- bendamustine hydrochloride
- product_names
- Bendamustine Hydrochloride
- ndc
- 63459-395, 63459-395-02, 63459-396, 63459-396-02, 63459-390, 63459-390-08, 63459-391, 63459-391-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en